Alprazolam and Seborrhoeic dermatitis - a phase IV clinical study of FDA data

Summary:

Seborrhoeic dermatitis is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are female, 50-59 old, also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Seborrhoeic dermatitis when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Seborrhoeic dermatitis?

Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp) is found to be associated with 362 drugs and 513 conditions by eHealthMe. Check the latest studies of Seborrhoeic dermatitis.

On Jul, 19, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 27 people (0.02%) have Seborrhoeic dermatitis.

Could Alprazolam cause Seborrhoeic dermatitis?

Among these 27 people:

What is the gender of people who have Seborrhoeic dermatitis when taking Alprazolam? *

female: 62.96 %
male: 37.04 %

What is the age of people who have Seborrhoeic dermatitis when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

What are other side effects people have besides Seborrhoeic dermatitis? *

High Blood Pressure: 12 people, 44.44%
Pain In Extremity: 10 people, 37.04%
Fatigue (feeling of tiredness): 10 people, 37.04%
Head Injury: 9 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 33.33%
Fall: 9 people, 33.33%
Skin Disorder (skin disease): 9 people, 33.33%
Weight Decreased: 8 people, 29.63%
Feeling Abnormal: 8 people, 29.63%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 8 people, 29.63%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 37.04%
Tropical Spastic Paresis (an incurable viral infection of the spinal cord that causes weakness in the legs): 7 people, 25.93%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 25.93%
Urticaria (rash of round, red welts on the skin that itch intensely): 7 people, 25.93%
Depression: 6 people, 22.22%
Osteoporosis (bones weak and more likely to break): 3 people, 11.11%
Breast Cancer Female: 2 people, 7.41%
Vitiligo (pigment is lost from areas of the skin): 1 person, 3.70%
High Blood Cholesterol: 1 person, 3.70%
Back Pain: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Seborrhoeic dermatitis?

- Check whether Seborrhoeic dermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (362 drugs)

Browse all the conditions that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (513 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.